Previous studies using bioassay demonstrated the presence of a vasoactive substance or substances in coronary sinus blood during myocardial reactive hyperemia which had, on bioassay, characteristics of adenosine and/or AMP. In the present studies, specific blockers were applied to an improved bioassay system to define more precisely the nature of the substance or substances and to determine whether it also appears during local cardiac hypoxia. In the anesthetized dog, coronary sinus blood was bioassayed in an isolated autologous kidney during reactive and hypoxic dilation. During reactive dilation, the bioassay kidney responded with a large resistance increase which was blocked by theophyUine and adenosine deaminase and converted to a decrease by adenosine autoblockade. The same was true for hypoxic dilation, except in this instance, only adenosine deaminase reduced the response (40%). TheophyUine and adenosine autoblockade eliminated responses of the bioassay organ to both exogenous adenosine and exogenous AMP, but adenosine deaminase was specific for adenosine. These results confirm that one or more vasoactive substances appear in sinus blood in vasoactive quantities during cardiac reactive dilation, and that the peak concentration correlates roughly with the peak flow. In addition, they show that this also is the case for hypoxic dilation. More importantly, they demonstrate that the substance almost certainly is adenosine in the case of reactive dilation, and that increased adenosine levels also are present during hypoxic dilation, but in addition, suggest that AMP sometimes appears in coronary sinus blood during severe cardiac hypoxia in the dog heart. Ore Res
BERNE and colleagues have implicated adenosine in the regulation of coronary blood flow (Berne 1963) . Biochemical analysis reveals adenosine and/ or its breakdown products (inosine and hypoxanthine) in cardiac tissue, pericardial fluid, and coronary sinus effluent during myocardial hypoxia (Beme, 1963; Olsson, 1970; Berne and Rubio, 1974) . It is, however, difficult to determine from these studies whether the concentration of adenosine at the myocardial arteriole is, in fact, high enough to produce vasodilation and whether the temporal sequence of its appearance correlates with the vascular response. In 1965, bioassay studies in our laboratory snowed that one or more substances appear in coronary sinus blood in vasoactive quantities during myocardial reactive hyperemia and that peak concentration correlates roughly with the peak flow (Scott et al., 1965) . This material has the bioassay characteristics of adenosine and/or AMP.
Because our studies failed to provide conclusive evidence that the substance is in fact adenosine or adenosine and AMP, and because it was subsequently shown that theophyUine, a competitive inhibitor of the vasodilation produced by exogenous adenosine or AMP (Afonso and O'Brien, 1970; Afonso, 1970; Biinger et al; 1975) , fails to alter greatly the reactive and hypoxic hyperemias (Bittar and Pauly, 1971; Afonso et al., 1972; Curnish et al., 1972; Merrill et al., 1978) , we have readdressed the problem. We have attempted, with the use of specific blockers, to identify more precisely the substance or substances that appear in coronary sinus blood during reactive hyperemia. In addition, we now have extended the studies to include hypoxic dilation.
Methods
Forty-two mongrel dogs (18-20 kg) of either sex were anesthetized with sodium pentobarbital, 30 mg/kg, iv. Ventilation was maintained with a positive-pressure respirator. The lung passively emptied against a resistance of 2 cm H2O. After completion of the necessary surgical procedures, heparin sodium 5 mg/kg, was given intravenously. All pressures were monitored continuously with low-volume displacement pressure transducers, which provided input into a direct writing oscillograph recorder.
The bioassay organ chosen was again the kidney, since previous studies show that its response to intra-arterially injected adenosine or AMP is VOL. 45, No. 4, OCTOBER 1979 unique, i.e., a resistance increase rather than a decrease (Scott et al., 1965; Thurau, 1964 ). An interesting but unexplained feature of the renal response to adenosine is that, during intra-arterial infusion at a high rate, the increased resistance gradually disappears, and then the kidney does not respond to bolus injection of adenosine, but responds in an exaggerated fashion to norepinephrine or sympathetic nerve stimulation (Hashimoto and Kokubun, 1971) . Thus, adenosine infusion produces a type of autoblockade (self-antagonism). Theophylline blocks the renal response to injected adenosine in a competitive manner (Oswald, 1975) , as it does in the heart (Biinger et al., 1975) . In the heart, it also competitively inhibits the coronary vascular response to the adenine nucleotides but is without effect on the responses to isoproterenol and acetylcholine (Biinger et al., 1975) . Adenosine deaminase degrades adenosine but not AMP. We took advantage of these drug properties in the present experiments.
Reactive Hyperemia and Adenosine Autoblockade
Reactive hyperemia was examined in a first series of experiments. The preparation is shown in Figure  1 . The heart was exposed via the left 5th intercostal space, and the left common coronary artery carefully was isolated and encircled with a loose ligature. This ligature subsequently was used to occlude the artery. The coronary sinus was cannulated via the right auricle with a specially made curved glass cannula. This cannula was tied in place with suture. A Y-tube was inserted in the effluent circuit. One branch provided blood to perfuse the bioassay kidney, and the other returned excess blood to the vena cava. A kidney was removed completely from ANTERIOR DESCENDING ARTERY JUGULAR VEIN VENA CAVA FIGURE 1 Schematic representation of the bioassay system. During left coronary artery occlusion, the kidney was perfused with caval blood drawn retrogradely through the extracorporeal circuit. P,, = coronary sinus pressure; P p •= renal perfusion pressure.
the body (bioassay organ). Renal blood flow rate was maintained constant (range, 120-250 ml/min) with a precalibrated perfusion pump (Sigamotor Inc., model T6SH). The renal vein of the bioassay kidney was split diagonally and opened to air. The isolated kidney was placed on a wire frame which covered the mouth of a glass funnel. Thus, the blood passed through the kidney and dripped freely into the funnel. The effluent from the funnel was returned to the dog by gravity feed via a femoral vein. Systemic blood pressure, renal perfusion pressure, and coronary sinus pressure were monitored continuously from catheters attached to Statham P23Gb, low-volume pressure transducers and recorded on a Hewlett-Packard direct-writing oscillograph. A PE-50 catheter was placed in the left common coronary artery via a branch of the circumflex artery for injection of adenosine and ATP. The major differences between this bioassay system and the one used previously (Scott et al., 1965) are: (1) The kidney was removed from the body, and (2) a vasoconstrictor agent was infused into the renal artery. The former allowed us to shorten circuit lag time from 15 to less than 5 seconds and stabilized the preparation by eliminating neurogenic vasoactivity. The latter raised renal resistance slightly, thereby allowing us to bioassay depressor as well as pressor agents. Two vasoconstrictor agents, epinephrine (10 /ig/ml) and barium chloride (2.0 mM), were used to elevate renal resistance. Both agents were dissolved in isotonic saline. Infusion rates were adjusted to produce a renal perfusion pressure similar to aortic pressure.
Once the preparation had been completed and the renal perfusion pressure was constant, we tested the renal perfusion pressure response to a left coronary artery occlusion of approximately 40 seconds. We also observed the responses to injections of adenosine and the adenine nucleotides into the left common coronary artery and into the extracorporeal circuit upstream to the perfusion pump. After these maneuvers, adenosine, 125 /ng/min, was infused into the renal artery. When the initial resistance increase had disappeared, the maneuvers were repeated. The infusion of adenosine then was discontinued and the maneuvers repeated again.
In some experiments, the epinephrine infusion was replaced by a barium chloride infusion, and responses to coronary artery occlusion were recorded. An infusion of phentolamine, diluted in isotonic saline to a concentration of 50 fig/ml, then was superimposed on the barium chloride infusion at a rate that blocked the kidney's response to 1-to 5-/xg injections of epinephrine and norepinephrine. The response to coronary artery occlusion again was observed.
Local Hypoxic Dilation, Adenosine Autoblockade, and Theophylline
The response to local cardiac hypoxia was examined in a second series of experiments. The prep-aration was as shown in Figure 1 , except that a second extracorporeal system, containing a lung isolated from another dog, was established between a femoral artery and the left common coronary artery. This system has been described in detail in previous communications Daugherty et al., 1967) . The circuit allowed the oxygen tension of the blood perfusing the left common coronary artery to be altered selectively. Flow rate was maintained constant at a rate that produced a coronary perfusion pressure similar to aortic pressure. In these experiments, oxygen tension was reduced by ventilating the lung with 0% O 2> 5% CO2, 95% N2 for 90 seconds. The control gas mixture was 20% O 2 , 5% CO 2 , 75% N 2 . Coronary and renal flow were approximately 120 and 100 ml/min, respectively. Intrarenal infusion of epinephrine was used to elevate renal resistance in all experiments.
Adenosine autoblockade of the kidney was established in nine experiments, as described above, by infusing adenosine, 100 /ig/min. In six other experiments, theophylline was infused into the renal artery at 19.1 mg/min; this created a calculated blood concentration of 10~3 M, blocked the responses to renal arterial injections of 0.25, 0.50, and 1.0 fig of adenosine, and attenuated greatly the reponses to injections of 10 and 20 jig of adenosine. Renal responses to cardiac hypoxia were observed before, during, and after these infusions.
Reactive and Hypoxic Dilation and Adenosine Deaminase
In a third series of experiments, responses of the bioassay organ were examined before and during administration of adenosine deaminase. The preparation was the same as in the second series of experiments, except that the bioassay circuit was lengthened to 200 cm, thereby increasing the lag time to 30 seconds. In addition, the circuit tubing was placed in a water bath at 37°C, and the adenosine deaminase was infused into the coronary artery. After these modifications, adenosine injected into the coronary vascular bed was without effect on the kidney. AMP, on the other hand, continued to produce an increase in renal resistance.
In this series, cardiac hypoxia again was produced by ventilating the isolated lung for 90 seconds with the oxygen-free gas mixture. Myocardial ischemia was produced by interrupting coronary perfusion for 30 seconds. The preparation also was challenged by injecting adenosine (10-50 fig) and AMP (20-40 jug) into the coronary circuit. All maneuvers were repeated during infusion of a solution of adenosine deaminase (3 mg/ml) into the coronary circuit at 1.9 ml/min. Epinephrine again was infused into the bioassay circuit to elevate and maintain renal resistance.
Statistical significance of all results was established by the Student's t-test modified for paired replicants. Figure 2 shows typical responses of the bioassay kidney to coronary occlusion and to injections of adenosine and ATP upstream and downstream to the heart. Coronary sinus pressure indicates the direction of changes in flow, since the catheter tip lay in a tube of constant diameter. It is apparent that release of a 20-second occlusion of the left common coronary artery produced reactive hyperemia and a prompt transient increase in renal vascular resistance. Adenosine injected upstream or downstream to the heart increased renal vascular resistance, as did ATP injected upstream. However, ATP injected downstream to the heart produced a biphasic renal response in this preparation. The same volume of saline given upstream to the heart had no effect on renal vascular resistance. Table 1 shows that the bioassay response during hyperemia appeared to progress with the duration of the occlusion. It also is evident that renal vascular resistance did not change during the occlusion. Figure 3 shows that the bioassay response to coronary occlusion and to adenosine and ATP injections still occurred in the presence of adrenergic blockade of the kidney. R-C, + 6 +36* +46* +69* PRA -bioassay kidney perfunion pressure; renal blood flow constant Ci, C? -pre-and postcontrol periods during which assay kidney was perfused with coronary sinus blood. O ™ occlusion period during which the kidney was perfused mainly with vena caval blood (a small fraction consisted of sinus blood derived from collateral vessels). R -period of reactive hyperemia during which the assay kidney was perfused with coronary sinus blood. Pressure is the peak value obtained.
Results
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" P < 0.05. Table 2 shows average bioassay responses to coronary occlusion before, during, and after adenosine autoblockade. The renal resistance increase was converted to a small decrease. The original response reappeared after the adenosine infusion was stopped. Table 3 shows that adenosine and AMP greatly increased renal resistance when administered into the circuit. Adenosine autoblockade markedly attenuated the responses to adenosine and AMP but had no effect on the responses to ADP and ATP. It is unfortunate that adenosine autoblockade also blocks the response to AMP. This, of course, means that this technique cannot be used to differentiate between these two substances. The response to adenosine and AMP promptly reappeared when the adenosine infusion was stopped. Note that in contrast to occlusion (Table 2) , adenosine or AMP, in the amounts used, did not produce a depressor response during adenosine autoblockade. Figure 4 shows that local cardiac hypoxia also produced a pressor response in the bioassay kidney and that this response was eliminated by adenosine autoblockade. Cardiac hypoxia was associated with a marked decrease in coronary resistance.
Local Hypoxic Dilation, Adenosine Autoblockade, and Theophylline
Average data from nine such experiments are shown in Table 4 . The area of the bioassay response was converted from a positive 352 sq mm to a negative 58 sq mm. After adenosine autoblockade, the response returned to a positive 414 sq mm. The changes in pressure were in the same direction as the changes in area. The pressor response to 0.5 j^g of adenosine, administered directly to the kidney, was blocked completely during the adenosine infusion. Again, a depressor response was not observed. Figure 5 shows that the renal response to cardiac hypoxia also can be eliminated by theophylline. Average data are shown in Table 5 . In contrast to adenosine autoblockade, theophylline, at the dose used, failed to completely eliminate the response. However, it did block completely the response to 0.5 fig of adenosine injected into the circuit. Theophylline also blocked the renal response to injected AMP. Thus, neither adenosine autoblockade nor theophylline blockade allow us to differentiate between adenosine and AMP.
It is evident from Figures 4 and 5 and Tables 4 and 5 that the renal response during local cardiac hypoxia greatly exceeded that produced by bolus injection of adenosine (0. 5 fig) . Thus, as in the previous group of experiments, it appears likely that rather large concentrations of adenosine and/or AMP were present in the sinus blood. 
Reactive and Hypoxic Dilation and Adenosine Deaminase
Results of a typical experiment are shown in Figure 6 . It is apparent that, during intracoronary adenosine deaminase infusion, the bioassay organ experiments. It is evident that adenosine deaminase completely eliminated the responses of the bioassay organ to intracoronary adenosine and to cardiac ischemia. Moreover, its response to cardiac hypoxia was reduced by 40% (in four of the nine dogs, theophylline subsequently was administered, and responses to adenosine and ischemia were blocked and the response to hypoxia was reduced, whereas that to AMP was augmented. The coronary vascular responses were not greatly different during drug infusion. 
Hypoxia
Hypoxia Hypoxia aminase regularly reduced renal perfusion pressure. This is not apparent in Table 1 , since the intrarenal infusion of epinephrine was increased to return perfusion pressure to the control level.
In four other dogs, the same experimental design and protocol were followed except that 5'-adenylic acid deaminase was administered, instead of adenosine deaminase. The enzyme came from the manufacturer (Sigma) suspended in a 66% glycerol-0.33 M KC1 solution. At its defined activity, approximately 10 ml/min of the solution had to be administered to deaminate 40 /ig of AMP to IMP per minute. This, of course, would elevate coronary potassium to unacceptable levels. To lower the potassium concentration to a tolerable level, the stock solution was dialyzed at 4°C against a pure glycerol solution. In each experiment, the dialyzed enzyme solution failed to alter the renal response to intracoronary bolus injections of AMP (10-40 ng) or the renal response to hypoxemic coronary sinus blood. Thus, it appeared that the enzyme activity was attenuated greatly by the dialysis and consequently could not be used to define a role for AMP in cardiac hypoxemic dilation.
Discussion
These studies show that local cardiac hypoxia produces the same response of the bioassay organ as was demonstrated for reactive hyperemia in our study in 1965 (Scott et al., 1965) . Furthermore, they show that the bioassay organ response to reactive dilation can be blocked by adenosine autoblockade, theophylline, and adenosine deaminase. Moreover, they show that the bioassay organ response to local cardiac hypoxia can be blocked by adenosine autoblockade and theophylline but is blocked only partially by adenosine deaminase. Finally, they demonstrate that all the agents eliminate the bioassay organ response to exogenous adenosine, but only adenosine autoblockade and theophylline eliminate the response to exogenous AMP. By inference then, adenosine is released during reactive and hypoxic hyperemia, and consideration should be given to the possibility that, in the dog, AMP sometimes is released also during severe hypoxic hyperemia. This, of course, is based on the assumption that the agents used are not "blocking" vasoactive sub-stances other than adenosine and AMP. Although one never can be certain that a given "blocker" is specific for one class of agents, it seems highly unlikely that three blockers with dissimilar modes of action would block adenosine and AMP and, in addition, also block some other vasoactive substance. The phentolamine experiments show that the bioassay organ response does not result from catecholamine release, and the isolation technique eliminates a neurogenic mechanism. We know of no substances other than adenosine and AMP that are blocked during adenosine autoblockade. The same applies to theophylline blockade in the case of naturally occurring substances with the exception that theophylline also competitively inhibits the VOL. 45, No. 4, OCTOBER 1979 responses to ATP and ADP in the isolated guinea pig heart (Biinger, 1975) . Finally, the only known action of adenosine deaminase is to degrade adenosine.
The conclusion that AMP might sometimes also be released during severe hypoxia of the dog heart is based on the observation that on the average adenosine deaminase reduced the bioassay organ response by only 40%. A more appealing argument for involvement of AMP in coronary hypoxemia dilation could be invoked if the experiments with adenylic acid deaminase had been positive. Unfortunately, these studies neither favor nor rule out participation of AMP in the response. In this regard, we recently have perfected a radiometric-enzymic analysis capable of detecting extremely low levels of AMP (20-40 ng/ml). In preliminary studies conducted in isolated, artificially perfused guinea pig hearts, we failed to measure an increase in AMP in coronary sinus perfusate after a brief period of coronary flow interruption or during severe cardiac hypoxia. These latter studies argue against a role for AMP in coronary flow regulation. How then can one explain the present finding that adenosine deaminase failed to alter the bioassay kidney response to coronary sinus blood during cardiac hypoxia, while theophylline completely eliminated this response? A simple straightforward explanation would be that more adenosine was released that could be deaminated by the amount of adenosine deaminase administered. However, the adenosine deaminase completely eliminated the bioassay organ response to intracoronary bolus injection of 50 fig of adenosine. Thus, for this explanation to be valid, the amount of adenosine released during hypoxia would have to be far greater than previous studies would lead one to expect (Berne and Rubio, 1974) . Moreover, in two of the nine experiments, the assay organs' response to hypoxia was greater during adenosine deaminase administration than before (yet it was blocked by theophylline). This would suggest that AMP, rather than adenosine, was responsible for the responses in these two dogs. On the other hand, in one of the nine experiments, adenosine deaminase completely neutralized the assay organ's response to hypoxia, arguing that adenosine was the sole cause of the response in this dog. Perhaps the release of adenosine and AMP in response to hypoxia varies from animal to animal and species to species.
Although it is impossible to quantify accurately the amounts of adenosine and AMP released in these studies, a comparison of the responses to exogenous adenosine and AMP with those to hypoxia and ischemia suggests that they were substantial. Nevertheless, we still cannot state with certainty that this is the only agent acting at the coronary arteriole. This study and studies of others (Liu et al., 1976; Baer and Drummond, 1968; Stowe et al., 1974) show that ATP administered into the coronary artery is degraded in a single pass; the degradation products include AMP (Liu et al., 1976) as weU as adenosine (Baer and Drummond, 1968) .
Thus, the agent in coronary sinus blood appears to be adenosine, although it is possible that the vasodilating agents at the coronary arteriolar level include ATP, ADP, and AMP, as well as adenosine. One might ask whether this is the reason why reactive dilation in the coronary vascular bed was not influenced by intracoronary infusion of adenosine deaminase. However, this agent also failed to influence coronary responses to exogenous adenosine. It therefore seems more likely that failure of adenosine deaminase to block coronary reactive dilation is related to the short exposure time.
Still to be addressed is the question: Why doesn't theophylline, an inhibitor of the vasodilating actions of adenosine and the adenine nucleotides, substantially reduce cardiac reactive hyperemia and hypoxic dilation? Several possibilities can be presented to explain this apparent contradiction. It is possible that, since theophylline is a competitive inhibitor of adenosine and adenine nucleotide vasodilation (Biinger et al., 1975) , the concentrations of theophylline used in previous studies were not high enough to inhibit substantially the amounts of these agents liberated. It is impossible to administer the concentration used in this study to the heart without producing marked changes in heart rate and contractile force. Second, changes in the concentrations of other agents during ischemia and hypoxia, i.e., H + , K + , O 2 , and changes in osmolality and other factors, may enhance the vasoactivity of adenosine and the adenine nucleotides. In this regard, it has been shown that the adenosine-induced relaxation of contractile tension of helical coronary arterial strips is inversely proportional to the P02 in the tissue bath (Gellai et al., 1973) . Also, in the isolated guinea pig heart, the minimal coronary vasodilator concentration of adenosine is reduced when the coronary perfusate pH is reduced from 7.20 to 6.89, and the coronary flow increases produced by higher adenosine concentrations are also larger at a pH of 6.89 than at 7.69 (Merrill et al., 1978) . Finally, it seems likely that several different vasoactive agents and the myogenic response act in concert to produce myocardial blood flow regulation. For example, we previously have reported increased hydrogen and potassium ion concentrations and increased osmolality in coronary sinus blood during the reactive hyperemia that follows occlusion of the left common coronary artery for 30 seconds (Scott and Radawski, 1971) . Oxygen tension probably also falls. All of these changes are in the direction to produce renal vasodilation and, consequently, could explain the dilation seen in the autoblocked bioassay organ during cardiac reactive hyperemia and hypoxic dilation. Thus, selective blockade of the actions of adenosine and the adenine nucleotides by theophylline might not affect the overall response.
